GlobeNewswire

Preclinical Data Show Annamycin Makes Pancreatic Cancer Responsive to Checkpoint Inhibitors, Opening a Combination Path with Immunotherapies
10/11/2026
Inhibition of CD8+ T cells shortens survival in Annamycin-treated mice, demonstrating the immune system is a functional contributor to Annamycin’s antitumor activity, not a bystander Annamycin achieves substantially [...]
Autonomix Medical Granted New U.S. Patent Strengthening Proprietary Catheter-Based Sensing Technology
10/11/2026
Latest patent expands intellectual property protection for advanced physiological signal acquisition and processing THE WOODLANDS, TX, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix [...]
Bon Secours Mercy Health names Shon Baker foundation president, chief philanthropy officer
10/11/2026
Veteran philanthropy executive will strengthen donor partnerships to advance the ministry’s mission, extend its impact and support continued growth CINCINNATI, Nov. 10, 2026 (GLOBE NEWSWIRE) -- CINCINNATI, Ohio (Nov. 10 [...]
Inviah Healthcare Technology Platform Moves from Beta to Full Launch in Illinois to Bring Doctors and Quality Healthcare Directly to Patients’ Homes
10/11/2026
Physician-led healthcare company connects patients through the Inviah mobile app with credentialed doctors on demand, making medical care more accessible and convenient CHICAGO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Inviah [...]
Priovant Announces Publication of Phase 2 BEACON Results for Brepocitinib in Cutaneous Sarcoidosis in JAMA Dermatology
10/11/2026
At Week 16, 69% of participants receiving brepocitinib 45 mg achieved "Clear" or "Almost Clear" skin, with at least a 2-category improvement, compared with 0% receiving placebo Improvements in skin disease activity were [...]
Pain clinics in Ontario call for transparency amid concerns over future treatment access
10/11/2026
Save Pain Clinics seeks answers on potential changes to OHIP-funded nerve blocks and interventional pain injections for chronic pain TORONTO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Patients and clinicians across Ontario are [...]
Novartis ianalumab two-year data at ACR show further improvements in Sjögren’s disease activity
10/11/2026
Patients continuing ianalumab saw further improvement in systemic disease activity through Week 108, with no new safety findings 1 Nearly two-thirds of patients on continuous ianalumab reached low disease activity at [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2026
10/11/2026
DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
10/11/2026
Nantes, le 10 novembre 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), une société de [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2026
10/11/2026
Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2026
10/11/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
CHRISTUS Health among nation's most digitally advanced health systems
10/11/2026
National recognition underscores CHRISTUS Health's commitment to using technology and innovation to enhance patient outcomes and support clinicians IRVING, Texas, Nov. 10, 2026 (GLOBE NEWSWIRE) -- CHRISTUS Health [...]
ORYZON Reports Third Quarter 2026 Financial Results and Provides Corporate Update
10/11/2026
Updated clinical data from three iadademstat studies to be presented at ASH 2026, including encouraging results from ALICE-2 in first-line AML (95% ORR, 84% CRc and 74% CR) and FRIDA in relapsed/refractory FLT3-mutated [...]
RECORDATI FIRST NINE MONTHS 2026: NET REVENUE +7.5%, EBITDA +7.7%, ADJUSTED NET INCOME +6.4%
10/11/2026
Consolidated net revenue of € 2,103.7 million in the first nine months of 2026, +7.5% or +9.4% on a like-for-like basis (3) at constant exchange rates (CER); adverse FX impact of € 35.6 million (-1.8%) EBITDA (1) of € [...]
Science 37 Named a BioSpace 2027 Best Place to Work
10/11/2026
Recognition celebrates the people behind its Direct-to-Patient Site model, the innovative, radically transparent culture, and the company's commitment to clinical quality MORRISVILLE, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE [...]
Levicept Presents New Data from Phase II Trial of LEVI-04, a Novel Non-Opioid Investigational Treatment for Osteoarthritis at ACR Convergence 2026
10/11/2026
Ex vivo data demonstrated LEVI-04 provides analgesia by inhibition of NT-3 Data deepen understanding of novel mechanism of action in osteoarthritis (OA), providing analgesia while preserving the physiological NGF [...]
Ozari Health Publishes 2026 Compounded Tirzepatide Price Report: Monthly Costs Range From $125 to $199 Across Seven Online Providers
10/11/2026
Compiled from each provider's published prices on October 19, 2026, the report finds that the lowest regular monthly price for compounded tirzepatide on plans of three months or less runs from $125 to $199, that twelve- [...]
Thanks, Birth Control Day Brings Real Stories and Accurate Information to Young People’s Social Media Feeds to Combat Misinformation
10/11/2026
Power to Decide’s 14th annual campaign meets the moment with new data and an invitation to share what birth control has made possible. Washington, D.C., Nov. 10, 2026 (GLOBE NEWSWIRE) -- On Thursday, November 12, Power [...]
Beacon Behavioral Partners Expands Houston Presence Through Partnership With One Behavioral
10/11/2026
Six-location practice strengthens Beacon’s growing network across Houston, Dallas-Fort Worth and Austin PLANO, Texas, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Beacon Behavioral Partners (BBP), a growing national network of [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum